LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Continente #
NA - Nord America 8.539
AS - Asia 5.494
EU - Europa 1.760
SA - Sud America 1.222
AF - Africa 275
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.308
Nazione #
US - Stati Uniti d'America 8.408
SG - Singapore 3.687
BR - Brasile 1.009
CN - Cina 754
VN - Vietnam 485
FI - Finlandia 347
IE - Irlanda 240
IT - Italia 229
DE - Germania 208
NG - Nigeria 191
FR - Francia 161
GB - Regno Unito 128
HK - Hong Kong 119
NL - Olanda 111
AR - Argentina 95
IN - India 91
BD - Bangladesh 70
CA - Canada 65
RU - Federazione Russa 58
SE - Svezia 51
MX - Messico 43
IQ - Iraq 36
PK - Pakistan 34
UA - Ucraina 32
PL - Polonia 31
TR - Turchia 26
CO - Colombia 25
EC - Ecuador 25
ID - Indonesia 25
JP - Giappone 25
ZA - Sudafrica 25
AT - Austria 21
ES - Italia 21
MK - Macedonia 21
PH - Filippine 21
CL - Cile 18
PY - Paraguay 17
BE - Belgio 16
VE - Venezuela 16
IL - Israele 15
SA - Arabia Saudita 14
UZ - Uzbekistan 14
AU - Australia 11
KE - Kenya 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
LT - Lituania 10
RO - Romania 10
AL - Albania 8
DZ - Algeria 8
HU - Ungheria 8
MY - Malesia 8
IR - Iran 7
MA - Marocco 7
NP - Nepal 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
GE - Georgia 6
LV - Lettonia 6
PE - Perù 6
CI - Costa d'Avorio 5
GR - Grecia 5
KR - Corea 5
OM - Oman 5
SN - Senegal 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
GT - Guatemala 4
KZ - Kazakistan 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
JM - Giamaica 3
LB - Libano 3
PA - Panama 3
PT - Portogallo 3
TH - Thailandia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
Totale 17.290
Città #
Singapore 1.592
Chandler 1.207
Wilmington 1.051
Dallas 762
Ashburn 556
The Dalles 515
San Mateo 402
Shanghai 388
San Jose 349
Helsinki 347
Ann Arbor 337
New York 278
Dublin 239
Boardman 208
Lawrence 204
Princeton 204
Benin City 191
Leawood 179
Ho Chi Minh City 170
Beijing 151
Paris 130
Hanoi 121
Hong Kong 113
Fairfield 87
São Paulo 84
Woodbridge 82
Milan 81
Amsterdam 73
Los Angeles 65
London 57
Santa Clara 45
Pune 35
Rio de Janeiro 33
Seattle 33
Falkenstein 30
Brooklyn 27
Orem 27
Da Nang 25
Lahore 23
Montreal 23
Warsaw 23
Belo Horizonte 22
Norwalk 22
Tokyo 22
Council Bluffs 21
Haiphong 21
Phoenix 21
Assago 20
Munich 20
Naples 20
Buenos Aires 19
Curitiba 19
Frankfurt am Main 18
San Diego 18
Toronto 18
Brussels 16
Campinas 16
Porto Alegre 16
Columbus 15
Dhaka 15
Mumbai 15
Atlanta 14
Johannesburg 14
Rome 14
Manchester 13
Fortaleza 12
Hải Dương 12
Mexico City 12
San Francisco 12
Tashkent 12
Goiânia 11
Recife 11
Boston 10
Chennai 10
Poplar 10
Abbiategrasso 9
Chicago 9
Guarulhos 9
Kocaeli 9
Salvador 9
Skopje 9
Stockholm 9
Uberlândia 9
Baghdad 8
Biên Hòa 8
Bogotá 8
Campo Grande 8
Guayaquil 8
Nairobi 8
Natal 8
Quito 8
Ribeirão Preto 8
Asunción 7
Brasília 7
Buffalo 7
City of London 7
Houston 7
Moscow 7
Mosul 7
Ninh Bình 7
Totale 11.288
Nome #
CLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY 372
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry 196
Safety of Romosozumab in women with cancer and osteoporosis at high risk of fractures 175
A 2019 update on TSH-secreting pituitary adenomas 126
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 125
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 119
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 110
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 106
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 103
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 101
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 100
G protein mutations in endocrine diseases 99
Central hypothyroidism and growth hormone treatment : clinical care 98
An Unusual Case of Recurrent Autoimmune Hypophysitis 98
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 98
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 97
G-Protein and Signalling in Pituitary Tumours 96
Parental origin of G(s)alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 93
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 92
A potential catastrophic trap: an unusually presenting sellar lesion 92
G protein abnormalities in pituitary adenomas 92
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 92
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 92
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 91
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 90
A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-Up 89
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 88
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 87
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 85
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 85
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 85
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 82
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 82
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management 82
A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells 82
Growth factors and human pituitary adenomas 81
Functional hypothalamic and drug-induced amenorrhea: an overview 81
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 81
Hormonal signaling and pituitary adenomas 80
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 80
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 80
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 80
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 79
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 79
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 79
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 79
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 78
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 77
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 77
Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification 77
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 76
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 76
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 76
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior 76
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 75
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 75
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 75
Bone disorders associated with acromegaly: mechanisms and treatment 74
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 74
GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency 74
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 73
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 73
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 73
Is the 250 mu g ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 73
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 73
A practical use of bone turnover markers in management of patients with skeletal fragility 72
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 72
GNAS imprinting and pituitary tumors 72
cAMP in the pituitary: An old messenger for multiple signals 72
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation 72
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 72
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 72
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 72
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 72
[Genetic changes in human pituitary adenomas] 72
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 72
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 71
Genetics of pituitary tumors: Focus on G-protein mutations 71
Central hypothyroidism - a neglected thyroid disorder 71
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 71
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 71
Focus on GH deficiency and thyroid function 71
Inactivating and activating mutations of the Gs alpha gene 71
Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients 71
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 71
Dopamine D-2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 71
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 70
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 70
COVID-19 vaccines and blood glucose control: Friend or foe? 69
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 69
Central hypothyroidism 69
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 69
Bilateral testicular masses and adrenal insufficiency: is congenital adrenal hyperplasia the only possible diagnosis? First two cases of TARTS described in Addison-only X-linked adrenoleukodystrophy and a brief review of literature 69
Pituitary incidentalomas 68
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 68
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 68
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 68
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19 68
cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion 67
Totale 8.701
Categoria #
all - tutte 116.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 0 0 0 0 173 10 197
2021/20221.008 31 5 7 226 7 8 32 132 143 115 237 65
2022/20233.127 448 141 308 348 287 268 25 253 536 291 178 44
2023/20241.821 122 203 333 112 44 269 103 105 48 28 185 269
2024/20253.066 66 37 64 64 53 296 236 327 427 673 421 402
2025/20266.691 997 409 868 825 233 278 1.983 374 347 377 0 0
Totale 17.545